BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30742944)

  • 21. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
    Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
    Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant Cell Tumor of Bone Without Giant Cells with a Long Clinical Course: A Case Report.
    Takase H; Kato I; Ito J; Kawabata Y; Okabe T; Takeyama M; Fujii S
    Int J Surg Pathol; 2023 Apr; 31(2):190-194. PubMed ID: 35502834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Utility of Genetic and Immunohistochemical
    Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Sin Y; Akane S; Sugaya J; Mori T; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2021 Nov; 34(6):1899-1910. PubMed ID: 34304386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone.
    Khazaei S; De Jay N; Deshmukh S; Hendrikse LD; Jawhar W; Chen CCL; Mikael LG; Faury D; Marchione DM; Lanoix J; Bonneil É; Ishii T; Jain SU; Rossokhata K; Sihota TS; Eveleigh R; Lisi V; Harutyunyan AS; Jung S; Karamchandani J; Dickson BC; Turcotte R; Wunder JS; Thibault P; Lewis PW; Garcia BA; Mack SC; Taylor MD; Garzia L; Kleinman CL; Jabado N
    Cancer Discov; 2020 Dec; 10(12):1968-1987. PubMed ID: 32967858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
    Ratnagiri R; Uppin S
    J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway.
    Lübbehüsen C; Lüke J; Seeling C; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Möller P; Barth TFE
    Sci Rep; 2019 Apr; 9(1):6458. PubMed ID: 31015476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-127 and miR-376a act as tumor suppressors by in vivo targeting of COA1 and PDIA6 in giant cell tumor of bone.
    Herr I; Sähr H; Zhao Z; Yin L; Omlor G; Lehner B; Fellenberg J
    Cancer Lett; 2017 Nov; 409():49-55. PubMed ID: 28866093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L; Dijkstra S; van de Sande M; Gelderblom H
    Curr Opin Oncol; 2020 Jul; 32(4):332-338. PubMed ID: 32541321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone.
    Ogura K; Hosoda F; Nakamura H; Hama N; Totoki Y; Yoshida A; Ohashi S; Rokutan H; Takai E; Yachida S; Kawai A; Tanaka S; Shibata T
    Genes Chromosomes Cancer; 2017 Oct; 56(10):711-718. PubMed ID: 28545165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological characteristics of a novel giant cell tumor cell line derived from spine.
    Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J
    Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation.
    Tsukamoto Y; Futani H; Kihara T; Watanabe T; Kumanishi S; Matsuo S; Hirota S; Ueda T; Yamamoto H; Yoshiya S
    Pathol Res Pract; 2018 Sep; 214(9):1504-1509. PubMed ID: 29970305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Denosumab Induces Neoplastic Stromal Cell Apoptosis
    Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
    Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2020 Oct; 33(4):1321-1328. PubMed ID: 32815117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India.
    Rekhi B; Dave V; Butle A; Dharavath B; Khetale S; Redhu AK; Singh R; Dutt A
    Indian J Pathol Microbiol; 2024 Feb; ():. PubMed ID: 38391356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of H3.3 G34W Distinguishes Giant Cell Tumor of Bone From Its Major Giant Cell-containing Bone and Soft Tissue Mimics, in Particular Aneurysmal Bone Cyst and Giant Cell Tumor of Soft Tissue.
    Creytens D
    Appl Immunohistochem Mol Morphol; 2020; 28(5):e47-e48. PubMed ID: 29489506
    [No Abstract]   [Full Text] [Related]  

  • 39. Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3.
    Lim J; Park JH; Baude A; Fellenberg J; Zustin J; Haller F; Krücken I; Kang HG; Park YJ; Plass C; Lindroth AM
    Sci Data; 2018 Dec; 5():180283. PubMed ID: 30532024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blue lacy matrix in giant cell tumour of bone with or without denosumab therapy.
    Toda Y; Ishihara S; Kawai A; Yoshida A
    Virchows Arch; 2023 Jul; 483(1):125-129. PubMed ID: 36447097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.